Prodrome Sciences publishes research demonstrating the role of plasmalogens in the cause of Alzheimer’s
Plasmalogen molecules, critical lipids required for brain and nerve function, have been researched extensively since Dr. Goodenowe (Founder and CEO, Prodrome Sciences) first published his hypothesis about the role of plasmalogens in dementia in 2007. The Alzheimer’s Association has even funded a clinical trial for Prodrome Sciences to make a natural plasmalogen supplement for study in Alzheimer’s patients. Prodrome Sciences’ newest paper on the topic is a major achievement that outlines the strong evidence that plasmalogen molecules play a key role in the cause of Alzhiemer’s.
Click here to view the paper online.
To view a video of Dr. Goodenowe explaining the science behind the Plasmalogen Hypothesis of Neurodegeneration click here.